Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 22381899)

1.

Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer.

Shah A, Efstathiou JA, Paly JJ, Halpern SD, Bruner DW, Christodouleas JP, Coen JJ, Deville C Jr, Vapiwala N, Shipley WU, Zietman AL, Hahn SM, Bekelman JE.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e13-9. doi: 10.1016/j.ijrobp.2011.11.072. Epub 2012 Feb 28.

PMID:
22381899
2.

Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.

Halpern SD, Karlawish JH, Casarett D, Berlin JA, Townsend RR, Asch DA.

Am Heart J. 2003 Dec;146(6):985-92.

PMID:
14660989
3.

Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.

Ihrig A, Keller M, Hartmann M, Debus J, Pfitzenmaier J, Hadaschik B, Hohenfellner M, Herzog W, Huber J.

BJU Int. 2011 Oct;108(8):1274-8. doi: 10.1111/j.1464-410X.2011.10082.x. Epub 2011 Mar 16.

PMID:
21410634
4.

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA.

Cancer. 2013 May 1;119(9):1729-35. doi: 10.1002/cncr.27956. Epub 2013 Feb 22.

5.

An assessment of willingness to participate in a randomized trial of arthroscopic knee surgery in patients with osteoarthritis.

Creel AH, Losina E, Mandl LA, Marx RJ, Mahomed NN, Martin SD, Martin TL, Millett PJ, Fossel AH, Katz JN.

Contemp Clin Trials. 2005 Apr;26(2):169-78.

PMID:
15837439
6.

Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.

Yoon M, Ahn SH, Kim J, Shin DH, Park SY, Lee SB, Shin KH, Cho KH.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1477-85. doi: 10.1016/j.ijrobp.2009.07.011. Epub 2009 Oct 30.

PMID:
19879701
7.

A conundrum for randomized controlled trials: experience from a small hepatocellular carcinoma trial.

Sato K, Sato T, Furuse J, Kasugai H, Konishi M, Kosuge T, Saito A, Sasaki Y, Takasaki K, Okusaka T.

Jpn J Clin Oncol. 2010 Oct;40(10):949-53. doi: 10.1093/jjco/hyq074. Epub 2010 May 21.

8.

Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.

Costenbader KH, Brome D, Blanch D, Gall V, Karlson E, Liang MH.

Arthritis Rheum. 2007 Feb 15;57(1):49-55.

9.

Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.

Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gockerman JP, Gautier M.

Cancer. 2003 Mar 15;97(6):1499-506.

10.

Who will enroll? Predicting participation in a phase II AIDS vaccine trial.

Halpern SD, Metzger DS, Berlin JA, Ubel PA.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):281-8.

PMID:
11464149
11.

Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials.

Carroll R, Antigua J, Taichman D, Palevsky H, Forfia P, Kawut S, Halpern SD.

Clin Trials. 2012 Jun;9(3):348-57. doi: 10.1177/1740774512438981. Epub 2012 Mar 2.

12.

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.

Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC.

Control Clin Trials. 2003 Jun;24(3):272-82.

PMID:
12757993
13.

Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.

Roach M 3rd, Lu J, Pilepich MV, Asbell SO, Mohiuddin M, Grignon D.

J Urol. 2003 Jan;169(1):245-50.

PMID:
12478146
14.

Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.

Nihei K, Ogino T, Onozawa M, Murayama S, Fuji H, Murakami M, Hishikawa Y.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):390-6. doi: 10.1016/j.ijrobp.2010.05.027. Epub 2010 Sep 9.

PMID:
20832180
15.

Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis.

Israni AK, Halpern SD, McFadden C, Israni RK, Wasserstein A, Kobrin S, Berns JS.

Kidney Int. 2004 Mar;65(3):990-8.

PMID:
14871419
16.

Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.

Cotter SE, Herrup DA, Friedmann A, Macdonald SM, Pieretti RV, Robinson G, Adams J, Tarbell NJ, Yock TI.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1367-73. doi: 10.1016/j.ijrobp.2010.07.1989. Epub 2010 Oct 8.

PMID:
20934266
17.

Altruism among participants in cancer clinical trials.

Truong TH, Weeks JC, Cook EF, Joffe S.

Clin Trials. 2011 Oct;8(5):616-23. doi: 10.1177/1740774511414444. Epub 2011 Aug 3.

PMID:
21813584
19.

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.

Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S.

Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23.

PMID:
18783735
20.

Understanding participation in a trial comparing cryotherapy and radiation treatment.

Eng M, Taylor L, Verhoef M, Ernst S, Donnelly B.

Can J Urol. 2005 Apr;12(2):2607-13.

PMID:
15877944
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk